Vertex Pharmaceuticals Incorporated (LON:0QZU)
London
· Delayed Price · Currency is GBP · Price in USD 393.58
+10.85 (2.84%)
At close: Aug 13, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 74.81 billion as of August 14, 2025. Its market cap has decreased by -25.20% in one year.
Market Cap
74.81B
Enterprise Value
67.07B
Revenue
8.33B
Ranking
n/a
PE Ratio
28.17
Stock Price
393.58
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 74.81B, an increase of 145,974.51%. That is a compound annual growth rate of 23.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.13B |
| GSK plc | 56.32B |
| Haleon | 31.67B |
| Smith & Nephew | 11.73B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.01B |
| HUTCHMED (China) | 1.93B |